The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Meningitis Vaccine Market Research Report 2024

Global Meningitis Vaccine Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1565152

No of Pages : 85

Ask Your Query

Synopsis

The global Meningitis Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Meningitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningitis Vaccine.

Report Scope

The Meningitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Meningitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • GlaxoSmithKline
  • Baxter International
  • Sanofi Pasteur
  • Merck
  • Novartis
  • Pfizer
  • Hualan
  • Zhejiang Tianyuan
  • Beijing Tiantan Biological

Segment by Type

  • Meningitis A+C
  • Meningitis ACWY135
  • Meningitis B

Segment by Application

  • Medical Care
  • Hospital

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Meningitis Vaccine Market Overview
1.1 Product Overview and Scope of Meningitis Vaccine
1.2 Meningitis Vaccine Segment by Type
1.2.1 Global Meningitis Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Meningitis A+C
1.2.3 Meningitis ACWY135
1.2.4 Meningitis B
1.3 Meningitis Vaccine Segment by Application
1.3.1 Global Meningitis Vaccine Market Value by Application: (2024-2030)
1.3.2 Medical Care
1.3.3 Hospital
1.4 Global Meningitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningitis Vaccine Revenue 2019-2030
1.4.2 Global Meningitis Vaccine Sales 2019-2030
1.4.3 Global Meningitis Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Meningitis Vaccine Market Competition by Manufacturers
2.1 Global Meningitis Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Meningitis Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Meningitis Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Meningitis Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningitis Vaccine, Product Type & Application
2.7 Meningitis Vaccine Market Competitive Situation and Trends
2.7.1 Meningitis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Meningitis Vaccine Players Market Share by Revenue
2.7.3 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meningitis Vaccine Retrospective Market Scenario by Region
3.1 Global Meningitis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Meningitis Vaccine Global Meningitis Vaccine Sales by Region: 2019-2030
3.2.1 Global Meningitis Vaccine Sales by Region: 2019-2024
3.2.2 Global Meningitis Vaccine Sales by Region: 2025-2030
3.3 Global Meningitis Vaccine Global Meningitis Vaccine Revenue by Region: 2019-2030
3.3.1 Global Meningitis Vaccine Revenue by Region: 2019-2024
3.3.2 Global Meningitis Vaccine Revenue by Region: 2025-2030
3.4 North America Meningitis Vaccine Market Facts & Figures by Country
3.4.1 North America Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Meningitis Vaccine Sales by Country (2019-2030)
3.4.3 North America Meningitis Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meningitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Meningitis Vaccine Sales by Country (2019-2030)
3.5.3 Europe Meningitis Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningitis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Meningitis Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Meningitis Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meningitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Meningitis Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Meningitis Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Meningitis Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Meningitis Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningitis Vaccine Sales by Type (2019-2030)
4.1.1 Global Meningitis Vaccine Sales by Type (2019-2024)
4.1.2 Global Meningitis Vaccine Sales by Type (2025-2030)
4.1.3 Global Meningitis Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Meningitis Vaccine Revenue by Type (2019-2030)
4.2.1 Global Meningitis Vaccine Revenue by Type (2019-2024)
4.2.2 Global Meningitis Vaccine Revenue by Type (2025-2030)
4.2.3 Global Meningitis Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Meningitis Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Meningitis Vaccine Sales by Application (2019-2030)
5.1.1 Global Meningitis Vaccine Sales by Application (2019-2024)
5.1.2 Global Meningitis Vaccine Sales by Application (2025-2030)
5.1.3 Global Meningitis Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Meningitis Vaccine Revenue by Application (2019-2030)
5.2.1 Global Meningitis Vaccine Revenue by Application (2019-2024)
5.2.2 Global Meningitis Vaccine Revenue by Application (2025-2030)
5.2.3 Global Meningitis Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Meningitis Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Meningitis Vaccine Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter International Meningitis Vaccine Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Pasteur Meningitis Vaccine Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Meningitis Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Meningitis Vaccine Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Meningitis Vaccine Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Hualan
6.6.1 Hualan Corporation Information
6.6.2 Hualan Description and Business Overview
6.6.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Meningitis Vaccine Product Portfolio
6.7.5 Hualan Recent Developments/Updates
6.8 Zhejiang Tianyuan
6.8.1 Zhejiang Tianyuan Corporation Information
6.8.2 Zhejiang Tianyuan Description and Business Overview
6.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhejiang Tianyuan Meningitis Vaccine Product Portfolio
6.8.5 Zhejiang Tianyuan Recent Developments/Updates
6.9 Beijing Tiantan Biological
6.9.1 Beijing Tiantan Biological Corporation Information
6.9.2 Beijing Tiantan Biological Description and Business Overview
6.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Tiantan Biological Meningitis Vaccine Product Portfolio
6.9.5 Beijing Tiantan Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningitis Vaccine Industry Chain Analysis
7.2 Meningitis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningitis Vaccine Production Mode & Process
7.4 Meningitis Vaccine Sales and Marketing
7.4.1 Meningitis Vaccine Sales Channels
7.4.2 Meningitis Vaccine Distributors
7.5 Meningitis Vaccine Customers
8 Meningitis Vaccine Market Dynamics
8.1 Meningitis Vaccine Industry Trends
8.2 Meningitis Vaccine Market Drivers
8.3 Meningitis Vaccine Market Challenges
8.4 Meningitis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock